Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects [PDF]
Frontiers in Medicine, 2021 Recently, the global emergence of emergomycosis, a systemic fungal infection caused by a novel dimorphic fungus Emergomyces species has been observed among immunocompromised individuals.
Arghadip Samaddar
exaly +4 more sources
Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. [PDF]
PLoS Neglected Tropical Diseases, 2018 Kenneth Crombie +9 more
doaj +6 more sources
In vitro manogepix susceptibility testing of South African Emergomyces africanus, Emergomyces pasteurianus, and Blastomyces emzantsi clinical isolates. [PDF]
Antimicrob Agents Chemother, 2023 ABSTRACT We performed in vitro antifungal susceptibility testing of manogepix against the yeast phase of 78 Emergomyces africanus , 2 Emergomyces pasteurianus, and 5 Blastomyces emzantsi isolates using a reference broth microdilution ...
Nzimande SP, Govender NP, Maphanga TG.
europepmc +3 more sources
A presumptive case of cutaneous emergomycosis in a female patient with HIV – Maseru, Lesotho [PDF]
Southern African Journal of Infectious Diseases, 2022 Emergomycosis is a recently described emerging opportunistic fungal infection among individuals living with HIV, in whom it is a cause of significant mortality and morbidity.
Waheeba M.H. Madani, Wayne Grayson
doaj +2 more sources
Cbp1, a fungal virulence factor under positive selection, forms an effector complex that drives macrophage lysis. [PDF]
PLoS Pathogens, 2022 Intracellular pathogens secrete effectors to manipulate their host cells. Histoplasma capsulatum (Hc) is a fungal intracellular pathogen of humans that grows in a yeast form in the host.
Dinara Azimova +8 more
doaj +2 more sources
Emergomycosis in Africa: Time to Pay Attention to This Emerging Deadly Fungal Infection [PDF]
International Journal of General Medicine, 2023 Chibuike Ibe,1 Nicholaus P Mnyambwa,2,3 Sayoki G Mfinanga2 1Department of Microbiology, Faculty of Biological Sciences, Abia State University, Uturu, Nigeria; 2National Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania ...
Ibe C, Mnyambwa NP, Mfinanga SG
doaj +2 more sources
First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope Cryptococcus neoformans [PDF]
FEMS Yeast Research, 2017 Cryptococcus neoformans is an opportunistic pathogen responsible for the AIDS-defining illness, cryptococcal meningitis. During the disease process, entry of cryptococcal cells into the brain is facilitated by virulence factors that include urease enzyme activity.
Chris Kenyon +2 more
exaly +5 more sources
Epidemiology of fungal diseases in Africa: A review of diagnostic drivers [PDF]
Current Medical Mycology, 2021 Background and Purpose: There has been a significant increase in the burden of fungal diseases in the last few decades which has imposed a global threat to the health of humans, animals, and plants.
Felix Bongomin, Samuel Fayemiwo
doaj +2 more sources
In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients. [PDF]
J Clin Microbiol, 2017 ABSTRACT Disseminated emmonsiosis is an important AIDS-related mycosis in South Africa that is caused by Emergomyces africanus , a newly described and renamed dimorphic fungal pathogen. In vitro antifungal susceptibility data can guide management.
Maphanga TG +6 more
europepmc +5 more sources
The pathogenesis of experimental Emergomycosis in mice. [PDF]
PLoS Neglected Tropical DiseasesEmergomyces africanus is a recently identified thermally-dimorphic fungal pathogen that causes disseminated infection in people living with advanced HIV disease. Known as emergomycosis, this disseminated disease is associated with very high case fatality
Maxine A Höft +8 more
doaj +2 more sources